BIOM-02. MUTATIONAL ANALYSIS AND SINGLE CELL SEQUENCING OF MELANOMA BRAIN METASTASES REVEALS BRAF STATUS CORRELATES WITH CLINICAL OUTCOME AND DIFFERENTIAL IMMUNE POPULATIONS

MLA

Harish Vasudevan, et al. “Biom-02. Mutational Analysis and Single Cell Sequencing of Melanoma Brain Metastases Reveals Braf Status Correlates with Clinical Outcome and Differential Immune Populations.” Neuro-Oncology, vol. 24, Nov. 2022, pp. vii3-vii4. EBSCOhost, https://doi.org/10.1093/neuonc/noac209.012.

APA

Harish Vasudevan, Cyrille Delley, Alexander Aabedi, Poojan Shukla, Minh Nguyen, Ramin A Morshed, Jacob S Young, Ben Demaree, Devan Diwanji, Shawn L Hervey-Jumper, Lauren Boreta, Shannon Fogh, Jean Nakamura, Philip Theodospoulos, Joanna J Phillips, Mariza Daras, Katy Tsai, Penny Sneed, Manish Aghi, … Adam Abate. (2022). Biom-02. Mutational Analysis and Single Cell Sequencing of Melanoma Brain Metastases Reveals Braf Status Correlates with Clinical Outcome and Differential Immune Populations. Neuro-Oncology, 24, vii3-vii4. https://doi.org/10.1093/neuonc/noac209.012

Chicago

Harish Vasudevan, Cyrille Delley, Alexander Aabedi, Poojan Shukla, Minh Nguyen, Ramin A Morshed, Jacob S Young, et al. 2022. “Biom-02. Mutational Analysis and Single Cell Sequencing of Melanoma Brain Metastases Reveals Braf Status Correlates with Clinical Outcome and Differential Immune Populations.” Neuro-Oncology 24 (November): vii3-vii4. doi:10.1093/neuonc/noac209.012.